Major Updates from the Pharmaceutical Benefits ...

By Staff Writer

August 22, 2023

The Pharmaceutical Benefits Advisory Committee (PBAC) has made several recommendations for drug listings on the Australian Pharmaceutical Benefits Scheme (PBS) after July 2023 meeting. Some highlights include:
Thermidas: A Breakthrough in Non-Invasive Skin Temperature Measurement
Ensuring Medicine Supply Chain Resilience in Disasters: A Grounded Approach
Empowering Ethiopia: Horizon Europe Grants €4M to Tackle Non-Communicable Dis...
Empowering Pharmacists: South African Court Ruling Greenlights Pharmacist-Pre...
Unlocking Health Equity through Digital Health Technologies
Advancing Antibiotic Use and Preventing Hearing Loss in Babies: Evidence-gene...
Unlocking the Value of Biosimilars: Challenges and Solutions
Decoding Research Integrity: Hierarchy of Evidence and Randomised Control Trials
WHO Approves Essential Medicines for Multiple Sclerosis while Obesity Drugs a...
Exposing the Hidden Costs: Hospitals Charging 500% More for Medicines
Buprenorphine and Telehealth: A New Era in Opioid Use Disorder Treatment
Bridging the Gap Between Inpatient and Outpatient Care: A Shift in European H...